Controlling in Vitro Insulin Amyloidosis with Stable Peptide Conjugates: A Combined Experimental and Computational Study

Journal of Physical Chemistry B

Volumn 119, Issue 50, 2015, Pages 15395-15406

  Mishra, Narendra Kumar ^a   Krishna Deepak, R N V ^a   Sankararamakrishnan, Ramasubbu ^a   Verma, Sandeep ^a  

^a INDIAN INSTITUTE OF TECHNOLOGY KANPUR   (India)

Author keywords

[No Author keywords available]

Indexed keywords

AGGLOMERATION; CHAINS; DICHROISM; HYDROPHOBICITY; IONIC STRENGTH; MOLECULAR DYNAMICS; PEPTIDES;

AGGREGATION PROCESS; COMPUTATIONAL STUDIES; HYDROPHOBIC INTERACTIONS; INSULIN FIBRILLATIONS; MECHANICAL AGITATION; MOLECULAR DYNAMICS SIMULATIONS; PARKINSON'S DISEASE; PHYSICOCHEMICAL ENVIRONMENTS;

INSULIN;

INSULIN; PEPTIDE;

AMYLOIDOSIS; ATOMIC FORCE MICROSCOPY; HUMAN; IN VITRO STUDY; MOLECULAR DYNAMICS; SCANNING ELECTRON MICROSCOPY;

AMYLOIDOSIS; HUMANS; IN VITRO TECHNIQUES; INSULIN; MICROSCOPY, ATOMIC FORCE; MICROSCOPY, ELECTRON, SCANNING; MOLECULAR DYNAMICS SIMULATION; PEPTIDES;

EID: 84952666806     PISSN: 15206106     EISSN: 15205207     Source Type: Journal    
DOI: 10.1021/acs.jpcb.5b08215     Document Type: Article

References (85)

1. Jucker, M.; Walker, L. C. Self propagation of pathogenic protein aggregates in neurodegenerative diseases Nature 2013, 501, 45-51 10.1038/nature12481
2. Fandrich, M. Oligomeric intermediates in amyloid formation: structure determination and mechanisms of toxicity J. Mol. Biol. 2012, 421, 427-440 10.1016/j.jmb.2012.01.006
3. Selkoe, D. J. Proteins folding in fatal ways Nature 2003, 426, 900-904 10.1038/nature02264
4. Dealwis, C.; Wall, J. Towards understanding the structure-function relationship of human amyloid disease Curr. Drug Targets 2004, 5, 159-171
5. Engel, M. F. M.; Khemtemourian, L.; Kleijer, C. C.; Meeldijk, H. J. D.; Jacobs, J.; Verkleij, A. J.; Kruijff, B. D.; Killian, J. A.; Hoppener, J. W. M. Membrane damage by human islet amyloid polypeptide through fibril growth at the membrane Proc. Natl. Acad. Sci. U. S. A. 2008, 105, 6033-6038 10.1073/pnas.0708354105
6. Bucciantini, M.; Rigacci, S.; Stefani, M. Amyloid aggregation: role of biological membranes and the aggregate-membrane system J. Phys. Chem. Lett. 2014, 5, 517-527 10.1021/jz4024354
7. Straub, J. E.; Thirumalai, D. Membrane Protein interaction are key to understanding the amyloid formation J. Phys. Chem. Lett. 2014, 5, 633-635 10.1021/jz500054d
8. Tofoleanu, F.; Brooks, B. R.; Buchete, N.-V. Modulation of alzheimer's protofilaments-membrane interactions by lipid headgroups ACS Chem. Neurosci. 2015, 6, 446-455 10.1021/cn500277f
9. Eisenberg, D.; Jucker, M. The Amyloid state of proteins in human diseases Cell 2012, 148, 1188-120 10.1016/j.cell.2012.02.022
10. Hard, T. Amyloid fibrils: formation, polymorphism and inhibition J. Phys. Chem. Lett. 2014, 5, 607-614 10.1021/jz4027612
11. Kelly, J. W. Towards an understanding of amyloidogenesis Nat. Struct. Biol. 2002, 9, 323-325 10.1038/nsb0502-323
12. Bucciantini, M.; Giannoni, E.; Chiti, F.; Baroni, F.; Formigli, L.; Zurdo, J.; Taddei, N.; Ramponi, G.; Dobson, C. M.; Stefani, M. Inherent toxicity of aggregates implies a common mechanism for protein misfolding diseases Nature 2002, 416, 507-511 10.1038/416507a
13. Sipe, J. D.; Cohen, A. S. Review: History of the amyloid fibril J. Struct. Biol. 2000, 130, 88-98 10.1006/jsbi.2000.4221
14. Tycko, R.; Wickner, R. B. Molecular structure of amyloid and prions fibrils: consensus versus controversy Acc. Chem. Res. 2013, 46, 1487-1496 10.1021/ar300282r
15. Mayer, J. P.; Zhang, F.; DiMarchi, R. D. Insulin structure and function Biopolymers 2007, 88, 687-713 10.1002/bip.20734
16. Li, S.; Leblanc, R. M. Aggregation of insulin at the interfaces J. Phys. Chem. B 2014, 118, 1181-1188 10.1021/jp4101202
17. Nayak, A.; Sorci, M.; Krueger, S.; Belfort, G. A. Universal pathway for amyloid nucleus and precursors formation for insulin Proteins: Struct., Funct., Genet. 2009, 74, 556-565 10.1002/prot.22169
18. Jorgensen, A. M. M.; Olsen, H. B.; Balschmidt, P.; Led, J. J. Solution structure of the superactive monomeric Des-[Phe(B25)] human insulin mutant: Elucidation of the structural basis for the monomerization of Des-Phe(B25) insulin and the dimerization of native insulin J. Mol. Biol. 1996, 257, 684-699 10.1006/jmbi.1996.0194
19. Wilhelm, K. R.; Yanamandra, K. M.; Gruden, A.; Zamotin, V.; Malisauskas, C. M.; Darinskas, V. A.; Forsgren, L.; Morozova-R, L. A. Immune reactivity towards insulin, its amyloid and protein S100B in blood in sera of parkinson's disease patients Eur. J. Neurolo. 2007, 14, 327-334 10.1111/j.1468-1331.2006.01667.x
20. Kachooei, E.; Moosavi-Movahedi, A. A.; Khodagholi, F.; Ramshini, H.; Shaerzadeh, F.; Sheibani, N. Oligomeric forms of insulin amyloid aggregation disrupt outgrowth and complexity of neuron-like PC12 cells PLoS One 2012, 7, e41344 10.1371/journal.pone.0041344
21. Whittingham, J. L.; Scott, D. J.; Chance, K.; Wilson, A.; Finch, J.; Brange, J.; Dodson, G. G. Insulin at pH-2: structural analysis of the conditions promoting insulin fibre formation J. Mol. Biol. 2002, 318, 479-490 10.1016/S0022-2836(02)00021-9
22. Nielsen, L.; Khurana, R.; Coats, R. A.; Frokjaer, S.; Brange, J.; Vyas, S.; Uversky, V. N. Effect of environmental factor on the kinetics of insulin fibril formation: elucidation of molecular mechanism Biochemistry 2001, 40, 6036-6046 10.1021/bi002555c
23. Sluzky, V.; Tamada, J. A.; Klibanov, A. M.; Langer, R. Kinetics of insulin aggregation in aqueous solutions upon agitation in the presence of hydrophobic surfaces Proc. Natl. Acad. Sci. U. S. A. 1991, 88, 9377-9381 10.1073/pnas.88.21.9377
24. B29-human insulin Structure 1995, 3, 615-622 10.1016/S0969-2126(01)00195-2
25. Devlin, G. L.; Knowles, T. P. J.; Squires, A.; Mccammon, M. G.; Nilsson, M. R.; Robinson, C. V.; Dobson, C. M.; Macphee, C. E. The component of polypeptide chains bovine insulin nucleates or inhibits aggregation of the patient protein in a conformational dependent manner J. Mol. Biol. 2006, 360, 497-509 10.1016/j.jmb.2006.05.007
26. Chinisaz, M.; Larijani, B.; Ebrahim Habibi, A. A molecular modeling study on full-length insulin: insights into initials events of amyloid formation Struct. Chem. 2014, 25, 1175-1185 10.1007/s11224-014-0395-5
27. Ivanova, M. I.; Sievers, S. A.; Sawaya, M. R.; Wall, J. S.; Eisenberg, D. Molecular basis for insulin fibril assembly Proc. Natl. Acad. Sci. U. S. A. 2009, 106, 18990-18995 10.1073/pnas.0910080106
28. Grudzielanek, S.; Velkova, A.; Shukla, A.; Smirnovas, V.; Tatarek-Nossol, M.; Rehage, H.; Kapurniotu, A.; Winter, R. Cytotoxicity of insulin within its self-assembly and amyloidogenic pathways J. Mol. Biol. 2007, 370, 372-384 10.1016/j.jmb.2007.04.053
29. Morris, K.; Serpell, L. From natural to designer self assembles biopolymer the structural characterization of fibrous proteins and peptides using fibre diffraction Chem. Soc. Rev. 2010, 39, 3445-3453 10.1039/b919453n
30. Mirmira, R. G.; Nakagawa, S. H.; Tager, H. S. Importance of the character and configuration of residue B24, B25 and B26 in insulin receptor interactions J. Biol. Chem. 1991, 266, 1428-1436
31. Zakova, L.; Kletvikova, E.; Veverka, V.; Lepsik, M.; Watson, C. J.; Turkengerg, J. P.; Jiracek, J.; Brzozowski, A. M. Structural integrity of the B24 site in human insulin is important for hormone functionality J. Biol. Chem. 2013, 288, 10230-10240 10.1074/jbc.M112.448050
32. Nakagawa, S.; Tager, H. S. Role of phenylalanine B25 side chain in directing insulin interactions with its receptor J. Biol. Chem. 1986, 261, 7332-7341
33. Hua, Q.-X.; Xu, B.; Huang, K.; Hu, S.-Q.; Nakagawa, S.; Jia, W.; Wang, S.; Whittaker, J.; Katsoyannis, P. G.; Weiss, M. A. Enhancing the activity of protein by stereospecific unfolding conformational life cycle of insulin and its evolutionary origins J. Biol. Chem. 2009, 284, 14586-14596 10.1074/jbc.M900085200
34. Waugh, D. F. Regeneration of insulin from insulin fibrils by the action of alkli J. Am. Chem. Soc. 1948, 70, 1850-1857 10.1021/ja01185a060
35. Hard, T.; Lendel, C. Inhibition of amyloid formation J. Mol. Biol. 2012, 421, 441-46 10.1016/j.jmb.2011.12.062
36. Gong, H.; He, Z.; Peng, A.; Zhang, X.; Cheng, B.; Sun, Y.; Zheng, L. N.; Huang, K. Effects of several quinone on insulin aggregation Sci. Rep. 2014, 4, 5648 10.1038/srep05648
37. Wang, S. S.-S.; Liu, K.-N.; Han, T.-C. Amyloid fibrillation and cytotoxicity of insulin are inhibited by the amphiphilic surfactants Biochim. Biophys. Acta, Mol. Basis Dis. 2010, 1802, 519-530 10.1016/j.bbadis.2010.02.008
38. Arora, A.; Ha, C.; Park, C. B. Inhibition of insulin amyloid formation by small stress molecules FEBS Lett. 2004, 564, 121-125 10.1016/S0014-5793(04)00326-6
39. Giger, K. L.; Vanam, R. P.; Seyrek, E.; Dubin, P. L. Suppression of insulin aggregation by Heparin Biomacromolecules 2008, 9, 2338-2344 10.1021/bm8002557
40. Hong, Y.; Meng, L.; Chen, S.; Leung, C.; W, T.; Da, L. T.; Faisal, M.; Silva, D. A.; Liu, J.; Lam, J. W. et al. Monitoring and inhibition of insulin fibrillation by small organic fluorogen with aggregation-induced emission characteristics J. Am. Chem. Soc. 2012, 134, 1680-1689 10.1021/ja208720a
41. Gibson, T. J.; Murphy, R. M. Inhibition of insulin fibrillogenesis with targeted peptide Protein Sci. 2006, 15, 1133-1141 10.1110/ps.051879606
42. Velkova, A.; Nossol, M. T.; Andreetto, E.; Kapurniotu, A. Exploiting cross-amyloid interactions to inhibit protein aggregation but not function: nanomolar affinity inhibition of insulin aggregation by an IAPP mimic Angew. Chem., Int. Ed. 2008, 47, 7114-7118 10.1002/anie.200801499
43. Wang, S. H.; Dong, X. Y.; Sun, Y. Effect of (-) epigallocatechin-3-gallate on human insulin fibrillation/aggregation kinetics Biochem. Eng. J. 2012, 63, 38-49 10.1016/j.bej.2012.02.002
44. Varughese, M. M.; Newman, J. Inhibitory effect of arginine on the aggregation of bovine insulin J. Biophys. 2012, 2012, Article id 434289 10.1155/2012/434289
45. Banerjee, V.; Kar, R. K.; Datta, A.; Parthasarathi, K.; Chatterjee, S.; Das, K. P.; Bhunia, A. Use of small peptide fragments as an inhibitors of insulin fibrillation process: A study by high and low resolution spectroscopy PLoS One 2013, 8, e72318 10.1371/journal.pone.0072318
46. Levy-Sakin, M.; Shreberk, M.; Daniel, Y.; Gazit, E. Targeting insulin amyloid assembly by small aromatic molecule: towards rational design of aggregation inhibitors Islets 2009, 1, 210-215 10.4161/isl.1.3.9609
47. Scherzer-Attali, R. S.; Convertino, M.; Pellarin, R.; Gazit, E.; Segal, D.; Caflisch, A. Methylation of tryptophan-modified naphthaquinone affects its inhibitory potential towards Aβ aggregation J. Phys. Chem. B 2013, 117, 1780-1789 10.1021/jp309066p
48. Cohen, T.; Frydman-Marom, A.-F.; Rechter, M.; Gazit, E. Inhibition of amyloid fibril formation and cytotoxicity by hydroxyindole derivative Biochemistry 2006, 45, 4727-4735 10.1021/bi051525c
49. Ghosh, S.; Verma, S. Phase fiiber growth in peptide conjugates: aggregation and disaggregation studies J. Phys. Chem. B 2007, 111, 3750-3757 10.1021/jp066546a
50. Mishra, N. K.; Joshi, K. B.; Verma, S. Inhibition of human and bovine insulin fibrillation by designed peptides conjugates Mol. Pharmaceutics 2013, 10, 3903-3912 10.1021/mp400364w
51. Sievers, S. A.; Karanicolas, J.; Chang, H. W.; Zhao, A.; Jiang, L.; Zirafi, O.; Stevens, J. T.; Munch, J.; Baker, D.; Eisenberg, D. Structure-based design of non-natural amino acid inhibitors of amyloid fibril formation Nature 2011, 475, 96-100 10.1038/nature10154
52. Porat, Y.; Abramowitz, A.; Gazit, E. Inhibition of amyloid fibril formation by polyphenols: structural similarity and aromatic interaction as a common inhibition mechanism Chem. Biol. Drug Des. 2006, 67, 27-37 10.1111/j.1747-0285.2005.00318.x
53. Gazit, E. A possible role of π-stacking in the self-assembly of amyloid fibrils FASEB J. 2002, 16, 77-83 10.1096/fj.01-0442hyp
54. Turnell, W. G.; Finch, J. T. Binding of the dye congo red to the amyloid protein pig insulin reveals a novel homology amongst amyloid forming peptide sequences J. Mol. Biol. 1992, 227, 1205-1223 10.1016/0022-2836(92)90532-O
55. Tugyi, R.; Uray, K.; Ivan, D.; Fellinger, E.; Perkins, A.; Hudecz, F. Partial D-amino acid substitution: improved enzymatic stability and preserved Ab recognition of a MUC2 epitope peptide Proc. Natl. Acad. Sci. U. S. A. 2005, 102, 413-418 10.1073/pnas.0407677102
56. Tjernberg, L. O.; Lilliehook, C.; Callaway, D. J. E.; Naslund, J.; Hahne, S.; Thyberg, J.; Terenius, L.; Nordstedt, C. Controlling the amyloid β-peptide fibril formation with protease-stable ligand J. Biol. Chem. 1997, 272, 12601-12605 10.1074/jbc.272.19.12601
57. Vassar, P. S.; Culling, C. F. A. Fluorescent stains with special reference to amyloid and connective tissues Arch. Pathol. 1959, 68, 487-494
58. Khurana, R.; Coleman, C. C.; Zanetti, I. S.; Carter, A.; Krishna, V.; Grover, R.K.; Roy, R.; Singh, S. Mechanism of thioflavin-T binding to amyloid fibrils J. Struct. Biol. 2005, 151, 229-238 10.1016/j.jsb.2005.06.006
59. Krebs, M. R. H.; Bromley, E. H. C.; Donald, A. M. The binding of thioflavin-T to amyloid fibrils: localization and implications J. Struct. Biol. 2005, 149, 30-37 10.1016/j.jsb.2004.08.002
60. Biancalana, M.; Koide, S. Molecular mechanism of thioflavin-t bindings to amyloid fibres Biochim. Biophys. Acta, Proteins Proteomics 2010, 1804, 1405-1412 10.1016/j.bbapap.2010.04.001
61. Sulatskaya, A. I.; Kuznetsova, I. M.; Turoverov, K. K. Interaction of thioflavin-t with amyloid fibrils: stoichiometry and affinity of dye binding, absorption spectra of bound dye J. Phys. Chem. B 2011, 115, 11519-11524 10.1021/jp207118x
62. Amdursky, N.; Gazit, E.; Rosenman, G. Formation of low-dimensional crystalline nucleus region during insulin amyloidogenesis process Biochem. Biophys. Res. Commun. 2012, 419, 232-237 10.1016/j.bbrc.2012.01.153
63. Jansen, R.; Dzwolak, W.; Winter, R. Amyloidogenic self-assembly of insulin aggregates probed by high resolution atomic force microscopy Biophys. J. 2005, 88, 1344-1353 10.1529/biophysj.104.048843
64. Krebs, M. R. H.; MacPhee, C. E.; Miller, A. F.; Dunlop, I. E.; Dobson, C. M.; Donald, A. M. The formation of spherulites by amyloid fibres of bovine insulin Proc. Natl. Acad. Sci. U. S. A. 2004, 101, 14420-14424 10.1073/pnas.0405933101
65. Burke, M. J.; Rougvie, M. A. Cross β protein structure Biochemistry 1972, 11, 2435-2439 10.1021/bi00763a008
66. Bouchard, M.; Zurdo, J.; Nettleton, E. J.; Dobson, C. M.; Robinson, C. V. Formation of insulin amyloid fibrils followed by FTIR simultaneously with CD and electron microscopy Protein Sci. 2000, 9, 1960-1967 10.1110/ps.9.10.1960
67. Loksztejn, A.; Dzwolak, W. Chiral bifurcation in aggregating insulin: an induced circular dichroism study J. Mol. Biol. 2008, 379, 9-16 10.1016/j.jmb.2008.03.057
68. Kurouski, D.; Dukor, R. K.; Lu, X.; Nafie, L. A.; Lednev, I. K. Normal and reversed supramolecular chirality of insulin fibrils probed by vibrational circular dichroism at the protofilament level of fibrils structure Biophys. J. 2012, 103, 522-531 10.1016/j.bpj.2012.04.042
69. Bohidar, H. B. Dynamic light scattering study of heat aggregation of insulin Colloid Polym. Sci. 1989, 267, 159-166 10.1007/BF01410355
70. Hanwell, M. D.; Curtis, D. E.; Lonie, D. C.; Vandermeersch, T.; Zurek, E.; Hutchison, G. R. Avogadro: an advanced semantic chemical editor, visualization, and analysis platform J. Cheminf. 2012, 4, 17 10.1186/1758-2946-4-17
71. Wang, J. M.; Wolf, R. M.; Caldwell, J. W.; Kollman, P. A.; Case, D. A. Development and testing of general amber force field J. Comput. Chem. 2004, 25, 1157-1174 10.1002/jcc.20035
72. Wang, J. M.; Wang, W.; Kollman, P. A. Antechamber: An accessory software package for molecular mechanical calculations Abstr. Pap. Am. Chem. 2001, S222, U403-U403
73. Pettersen, E. F.; Goddard, T. D.; Huang, C. C.; Couch, G. S.; Greenblatt, D. M.; Meng, E. C.; Ferrin, T. E.UCSF chimera -A visualization system for exploratory research and analysis J. Comput. Chem. 2004, 25, 1605-1612 10.1002/jcc.20084
74. Sousa da Silva, A. W.; Vranken, W. F. ACPYPE-AnteChamberPYthon parser interface BMC Res. Notes 2012, 5, 367 10.1186/1756-0500-5-367
75. Jakalian, A.; Jack, D. B.; Bayly, C. I. Fast, efficient generation of high-quality atomic charges. AM1-BCC model: II. parameterization and validation J. Comput. Chem. 2002, 23, 1623-1641 10.1002/jcc.10128
76. Hess, B.; Kutzner, C.; van der Spoel, D.; Lindahl, E. GROMACS 4: algorithms for highly efficient, load-balanced, and scalable molecular simulation J. Chem. Theory Comput. 2008, 4, 435-447 10.1021/ct700301q
77. Hornak, V.; Abel, R.; Okur, A.; Strockbine, B.; Roitberg, A.; Simmerling, C. Comparison of multiple amber force fields and development of improved protein backbone parameters Proteins: Struct., Funct., Genet. 2006, 65, 712-725 10.1002/prot.21123
78. Jorgensen, W. L.; Chandrasekhar, J.; Madura, J. D.; Impey, R. W.; Klein, M. L. Comparison of simple potential functions for simulating liquid water J. Chem. Phys. 1983, 79, 926-935 10.1063/1.445869
79. Parrinello, M.; Rahman, A. polymorphic transitions in single-crystals-a new molecular-dynamics Method J. Appl. Phys. 1981, 52, 7182-7190 10.1063/1.328693
80. Cheng, A. L.; Merz, K. M. Application of the Nose-Hoover chain algorithm to the study of protein dynamics J. Phys. Chem. 1996, 100, 1927-1937 10.1021/jp951968y
81. Essmann, U.; Perera, L.; Berkowitz, M. L.; Darden, T.; Lee, H.; Pedersen, L. G. A Smooth particle mesh ewald method J. Chem. Phys. 1995, 103, 8577-8593 10.1063/1.470117
82. Laskowski, R. A.; Swindells, M. B. LigPlot+: Multiple ligand-protein interaction diagrams for Drug Discovery J. Chem. Inf. Model. 2011, 51, 2778-2786 10.1021/ci200227u
83. Haas, J.; Vohringer-Martinez, E.; Bogehold, A.; Matthes, D.; Hensen, U.; Pelah, A.; Abel, B.; Grubmuller, H. Primary Steps of pH-dependent insulin aggregation kinetics are governed by conformational Flexibility ChemBioChem 2009, 10, 1816-1822 10.1002/cbic.200900266
84. Ma, B. Y.; Nussinov, R. Simulations as analytical tools to understand protein aggregation and predict amyloid conformation Curr. Opin. Chem. Biol. 2006, 10, 445-452 10.1016/j.cbpa.2006.08.018
85. Jain, A.; Sankararamakrishnan, R. Dynamics of noncovalent Interactions in all-alpha and all-beta class proteins: implications for the stability of amyloid aggregates J. Chem. Inf. Model. 2011, 51, 3208-3216 10.1021/ci200302q